Mcintyre Freedman & Flynn Investment Advisers Inc Abbott Laboratories Transaction History
Mcintyre Freedman & Flynn Investment Advisers Inc
- $139 Billion
- Q2 2024
A detailed history of Mcintyre Freedman & Flynn Investment Advisers Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Mcintyre Freedman & Flynn Investment Advisers Inc holds 2,490 shares of ABT stock, worth $293,147. This represents 0.19% of its overall portfolio holdings.
Number of Shares
2,490
Previous 2,490
-0.0%
Holding current value
$293,147
Previous $283 Million
8.58%
% of portfolio
0.19%
Previous 0.21%
Shares
1 transactions
Others Institutions Holding ABT
# of Institutions
3,175Shares Held
1.33BCall Options Held
8.62MPut Options Held
7.18M-
Vanguard Group Inc Valley Forge, PA166MShares$19.6 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$15.4 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.76 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.45 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.74 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $206B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...